DOCSL Stock Overview
Designs, develops, procures, markets, sells, and distributes footwear under the Dr.
Snowflake Score | |
---|---|
Valuation | 6/6 |
Future Growth | 1/6 |
Past Performance | 2/6 |
Financial Health | 5/6 |
Dividends | 3/6 |
Rewards
Risk Analysis
Dr. Martens plc Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | UK£0.55 |
52 Week High | UK£1.27 |
52 Week Low | UK£0.49 |
Beta | 0.10 |
11 Month Change | -2.57% |
3 Month Change | -20.73% |
1 Year Change | -53.35% |
33 Year Change | -85.20% |
5 Year Change | n/a |
Change since IPO | -87.92% |
Recent News & Updates
Recent updates
Shareholder Returns
DOCSL | GB Luxury | GB Market | |
---|---|---|---|
7D | 0.6% | 4.2% | -1.1% |
1Y | -53.3% | -41.8% | 10.2% |
Return vs Industry: DOCSL underperformed the UK Luxury industry which returned -42.5% over the past year.
Return vs Market: DOCSL underperformed the UK Market which returned 11.1% over the past year.
Price Volatility
DOCSL volatility | |
---|---|
DOCSL Average Weekly Movement | 6.6% |
Luxury Industry Average Movement | 6.5% |
Market Average Movement | 4.8% |
10% most volatile stocks in GB Market | 9.4% |
10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: DOCSL's share price has been volatile over the past 3 months compared to the UK market.
Volatility Over Time: DOCSL's weekly volatility (7%) has been stable over the past year, but is still higher than 75% of UK stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1945 | 2,630 | Kenny Wilson | www.drmartensplc.com |
Dr. Martens plc designs, develops, procures, markets, sells, and distributes footwear under the Dr. Martens brand name in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company was founded in 1945 and is based in London, the United Kingdom.
Dr. Martens plc Fundamentals Summary
DOCSL fundamental statistics | |
---|---|
Market cap | UK£531.13m |
Earnings (TTM) | UK£69.20m |
Revenue (TTM) | UK£877.10m |
7.7x
P/E Ratio0.6x
P/S RatioIs DOCSL overvalued?
See Fair Value and valuation analysisEarnings & Revenue
DOCSL income statement (TTM) | |
---|---|
Revenue | UK£877.10m |
Cost of Revenue | UK£301.90m |
Gross Profit | UK£575.20m |
Other Expenses | UK£506.00m |
Earnings | UK£69.20m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Nov 28, 2024
Earnings per share (EPS) | 0.072 |
Gross Margin | 65.58% |
Net Profit Margin | 7.89% |
Debt/Equity Ratio | 80.0% |
How did DOCSL perform over the long term?
See historical performance and comparison